Long COVID Atlas
Text Theme
Support

This page is educational and not a substitute for care. If you are struggling with your mood or having thoughts of suicide, please reach out now. In the US you can call or text 988 (Suicide and Crisis Lifeline), any time. Elsewhere, contact a local crisis line or someone you trust. These feelings can be a symptom of a treatable illness, and help works.

Treatment · Mood

Treat the biological substrate (anti-inflammatory, sleep, POTS, pacing)

Sometimes the most effective way to lift mood in long COVID is not to target mood directly, but to treat the biological drivers underneath it: inflammation, broken sleep, orthostatic symptoms, and the boom-and-bust of overexertion. No treatment is approved for long COVID, and addressing these modifiable drivers often eases depression and anxiety as a knock-on effect. This page makes the case for treating the substrate.

Mood in long COVID often improves when you treat its physical drivers: sleep, orthostatic symptoms, pacing, and inflammation. No treatment is approved for the disease; this approach addresses the modifiable causes.

Start here: treat the cause of the low mood

No treatment is approved for long COVID, and not every low mood in it is best treated as a mood disorder. Much of the depression and anxiety is fed by physical drivers, and treating those can lift the mood without a single drug aimed at mood itself. That is the idea behind treating the substrate.

It is not a rejection of antidepressants, which have their place. It is a recognition that if poor sleep, standing intolerance, and repeated crashes are grinding you down, fixing those removes a real cause of the distress rather than only managing the symptom.

targets modifiable driverslow certainty, thin direct evidence

Sleep first

Stay under the line, or the crash followsenergy thresholdpaced: sustainablepush overcrash, delayed
Stabilising the physical drivers, sleep, orthostasis, exertion, eases the mood layer they feed.

Disrupted, unrefreshing sleep is near-universal in long COVID and a powerful driver of low mood, poor concentration, and pain sensitivity. Treating insomnia, sleep apnoea where present, and the day-night rhythm is often the single highest-yield move for how a person feels.

The gain compounds. Better sleep steadies mood, sharpens thinking, and raises the energy ceiling that everything else draws on. It is unglamorous and it frequently does more for mood than any direct mood treatment on its own.

Orthostatic symptoms and pacing

Living with a racing heart, dizziness, and the fear of fainting is itself depressing and anxiety-provoking. Treating orthostatic intolerance with fluids, salt, compression, and the right medications removes a constant physical stressor that feeds the mood layer.

So does breaking the boom-and-bust cycle. Pacing prevents the repeated crashes that follow overexertion, and with them the demoralisation of being punished for every good day. Stability itself is good for mood.

Inflammation and the body-mind link

There is a biological basis for treating the substrate. Inflammation can produce low mood and fatigue directly through effects on the brain, which is part of why depression is so common after infection. Where an inflammatory or metabolic driver can be identified and addressed, mood can follow.

This does not mean unproven anti-inflammatory cocktails are warranted. It means the mood symptom may be downstream of a physical process, and that finding and treating that process, where one exists, is a legitimate route to feeling better. The same logic argues against chasing unproven anti-inflammatory protocols, which carry their own risks without the evidence to justify them.

Reducing the medication load

People with complex long COVID often accumulate many medications, some of which dull mood, disturb sleep, or add side effects that masquerade as new symptoms. Part of treating the substrate is subtraction: reviewing the list and removing what is not earning its place.

A careful deprescribing review can lift fog and flatness that were drug effects all along. It is a quiet, low-cost intervention that fits the same philosophy: fix the modifiable physical contributors before stacking another agent on top. Sedating antihistamines, some sleep aids, and certain blood-pressure agents are common culprits worth a second look with your prescriber.

subtraction can help as much as addition

How to sequence it

A sensible order is to stabilise sleep, treat orthostatic symptoms, establish pacing, and review medications, then see what mood remains. Often the burden is much lighter once those drivers are handled, and any remaining mood symptom is clearer to target.

This approach pairs naturally with direct mood treatment rather than competing with it. If depression or anxiety persists after the substrate is addressed, that is exactly when an antidepressant trial is most rational, aimed at what is left rather than at everything at once.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • How much of long COVID mood burden is driven by sleep, orthostasis, and exertion versus a primary mood process.
  • Whether treating physical drivers measurably outperforms or complements direct mood treatment.
  • Which inflammatory or metabolic drivers, when treated, actually improve mood.
  • The best sequence and combination of substrate treatments.
  • How much benefit comes simply from deprescribing.
  • Whether early substrate treatment prevents mood symptoms from entrenching.

What this means for you

If your low mood sits on top of broken sleep, orthostatic symptoms, and repeated crashes, treating those drivers is often the most effective and durable way to feel better, and it addresses a real cause rather than only the symptom. Sleep is usually the place to start.

This is not instead of antidepressants but alongside them. Stabilise the physical drivers first, then target any mood symptom that remains. If distress is severe at any point, treat it directly and get support without waiting for the rest to be solved.

References

Each reference links to the source on PubMed, PMC, or the publisher.

  1. Bonnet U, Juckel G. Impact of antidepressants on COVID-19 and post-acute COVID-19 syndrome: scoping review. Fortschr Neurol Psychiatr 2024.
  2. Vernon SD et al. Post-exertional malaise among people with long COVID compared to ME/CFS. Work 2023.

Associated topics